Opinion statement
The incorporation of endovascular interventions into mainstream clinical practice for patients with deep vein thrombosis (DVT) has been changing rapidly as a result of four major trends. First, there now is a much greater appreciation among practicing physicians of the major impact of the postthrombotic syndrome (PTS) on DVT patients’ late quality of life. Second, there have been rapid advances in the methods by which thrombus can be rapidly removed using endovascular techniques, resulting in greater efficiency and treatment safety. Third, these changes together have spurred a major change in recommended DVT treatment paradigms: there is now published expert consensus that adjunctive endovascular DVT thrombolysis should be strongly considered as a first-line treatment strategy for selected patients with extensive acute proximal DVT. Finally, DVT researchers from multiple subspecialties have finally come together in a major multidisciplinary clinical trial project to subject endovascular DVT thrombolysis to the rigorous scientific testing that is needed for clinicians to be confident in its efficacy, safety, and cost-effectiveness as a first-line DVT treatment strategy. Pending the results of this and other studies, medical physicians should routinely inform DVT patients about the long-term consequences of DVT; ensure that they understand the importance of anticoagulant therapy and elastic compression stockings in preventing PTS; provide a balanced discussion of the risks, benefits, and uncertainties associated with endovascular DVT thrombolysis to patients with extensive proximal DVT; and develop collaborative clinical and research relationships with physicians experienced with endovascular DVT therapy.
Similar content being viewed by others
References and Recommended Reading
Heit JA, Cohen AT, Anderson FA, for the VTE Impact Assessment Group: Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the USA [abstract]. Blood 2005, 106:267a.
Prandoni P, Lensing AW, Prins MH, et al.: Below-knee elastic compression stockings to prevent the post-thrombotic syndrome. Ann Intern Medicine 2004, 141:249–256.
Brandjes DP, Buller HR, Heijboer, H, et al.: Randomized trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997, 349:759–762.
Prandoni P, Lensing A, Cogo A, et al.: The long term clinical course of acute deep venous thrombosis. Ann Intern Med 1996, 125:1–7.
Hull RD, Raskob GE, Brant RF, et al.: Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Arch Intern Med 1997, 157:2562–2568.
Partsch H, Kaulich M, Mayer W. Immediate mobilization in acute vein thrombosis reduces post-thrombotic syndrome. Int Angiol 2004, 23:206–212.
Kahn SR, Ducruet T, Lamping DL, et al.: Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med 2005, 165:1173–1178.
Beyth RJ, Cohen AM, Landefeld CS: Long-term outcomes of deep vein thrombosis. Arch Intern Med 1995, 155:1031–1037.
Kahn SR, Hirsch A, Shrier I.: Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002, 162:1144–1148.
Delis KT, Bountouroglou D, Mansfield AO: Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 2004, 239:118–126.
Caprini JA, Botteman MF, Stephens JM, et al.: Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health 2003, 6:59–74.
Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH: Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984, 76:393–397.
Semba CP, Dake MD: Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 1994, 191:487–494.
Mewissen WM, Seabrook GR, Meissner MH, et al.: Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999, 211:39–49.
Comerota AJ, Throm RC, Mathias SD, et al.: Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000, 32:130–137.
AbuRahma AF, Perkins SE, Wulua JT, et al.: Iliofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 2001, 233:752–760.
Elsharawy M, Elzayat E: Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg 2002, 24:209–214.
Vedantham S, Grassi CJ, Ferral H, et al.: Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. J Vasc Interv Radiol 2006, 17:417–434.
Kim HS, Patra A, Paxton BE, et al.: Adjunctive percutaneous mechanical thrombectomy for lower-extremity deep vein thrombosis: clinical and economic outcomes. J Vasc Interv Radiol 2006, 17:1099–1104.
Lin PH, Zhou W, Dardik A, et al.: Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep vein thrombosis. Am J Surg 2006, 192:782–788.
Bush RL, Lin PH, Bates JT, et al.: Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. J Vasc Surg 2004, 40:965–970.
Cynamon J, Stein EG, Dym J, et al.: A new method for aggressive management of deep vein thrombosis: retrospective study of the power pulse technique. J Vasc Interv Radiol 2006, 17:1043–1049.
O’sullivan GJ, Lohan DG, Gough N, et al.: Pharmacomechanical thrombectomy of acute deep vein thrombosis with the Trellis-8 isolated thrombolysis catheter. J Vasc Interv Radiol 2007, 18:715–724.
Hilleman DE, Razavi MK.: Clinical and economic evaluation of the Trellis-8 infusion catheter for deep vein thrombosis. J Vasc Interv Radiol 2008, 19:377–383.
Parikh SR, Motarjeme A, McNamara TO, et al.: Ultrasound-accelerated thrombolysis for the treatment of deep vein thrombosis: initial clinical experience. J Vasc Interv Radiol 2008, 19:521–528.
Buller HR, Agnelli G, Hull RD, et al.: Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126(3 Suppl):401S–428S.
Vedantham S, Millward SF, Cardella JF, et al.: Society of Interventional Radiology position statement: treatment of acute iliofemoral deep vein thrombosis with use of adjunctive catheter-directed intrathrombus thrombolysis. J Vasc Interv Radiol 2006, 17:613–616.
Vedantham S.: Interventions for deep vein thrombosis: re-emergence of a promising therapy. Am J Med 2008, 121:S28–S39.
Kearon C, Kahn SR, Agnelli G, et al.: Antithrombotic therapy for venous thromboembolic disease. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:454S–545S.
Ginsberg JS, Hirsh J, Julian J, et al.: Prevention and treatment of postphlebitic syndrome: results of a 3-part study. Arch Intern Med 2001, 16:2105–2109.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vedantham, S. Thrombolytic therapy for deep vein thrombosis. Curr Treat Options Cardio Med 11, 129–135 (2009). https://doi.org/10.1007/s11936-009-0013-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11936-009-0013-9